Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2012
10/17/2012EP2509954A1 4 -oxo- 1h -quinoline- 3 - carboxamides as modulators of atp -binding cassette transporters
10/17/2012EP2509951A1 Novel cationic aminopyridines, dye composition comprising a cationic aminopyridine, processes therefor and uses thereof
10/17/2012EP2509950A1 5-amino- 4-hydroxypentoyl amides
10/17/2012EP2509949A2 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
10/17/2012EP2509946A1 Spiro indole - cyclopropane indolinones useful as ampk modulators
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741240A Pyrimidine compounds as delta opioid receptor modulators
10/17/2012CN102741239A Bicyclic compounds as alpha4beta2 nicotinic acetylcholine receptor ligands
10/17/2012CN102741227A Aryl benzylamine compounds
10/17/2012CN102741226A 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
10/17/2012CN102731543A Siliceous N-substituted alkyloxy hindered amine compound and its preparation method
10/17/2012CN102731487A 4,4'-dicarboxy-2,2'-bipyridine derived tridentate ligand, metal complex containing the same, and application thereof
10/17/2012CN102731485A 4-(substituted phenylamino)quinazoline derivative, its preparation method, pharmaceutical composition and application
10/17/2012CN102731483A Method for preparing 5-methoxyl-2-[[(4-methoxyl-3,5-dimethyl-2-pyridyl)-methyl]-sulfenyl]-1H-benzimidazole
10/17/2012CN102731482A Pymeprazole crystal form B
10/17/2012CN102731481A Pymeprazole crystal form D
10/17/2012CN102731480A Pymeprazole crystal form E
10/17/2012CN102731479A Organic ligand, rare earth organic fluorescent probe material thereof and preparation method thereof
10/17/2012CN102731478A Preparation method of (R)-2-[[[3[methyl-4-nitro-2-pyridyl]methyl]sulfinyl]benzimidazole
10/17/2012CN102731477A Pyrazoloquinoline compound and derivatives thereof, as well as preparation method and application of pyrazoloquinoline compound and derivatives thereof
10/17/2012CN102731476A Benzo-cycloheptyl-pyridine derivatives containing cyanoguanidine structure, preparation method, and pharmaceutical compositions and medicinal application thereof
10/17/2012CN102731475A Method for recycling nicotine and hemicellulose in tobacco waste
10/17/2012CN102731474A Preparation method of imatinib
10/17/2012CN102731473A Plant source nicotine intermittent carbonization-decarboxylation extraction technology and its device
10/17/2012CN102731416A 1-(aryl methyl)-quinazoline-2,4-dione as PARP inhibitor and its application
10/17/2012CN102731413A Urea compound and its preparation method, intermediate and use
10/17/2012CN102731409A Pyridazinone compound, and pharmaceutical compositions, preparation method and use thereof
10/17/2012CN102731403A Insecticidal isoxazolines
10/17/2012CN102731401A Geldanamycin derivatives, preparation method thereof, and uses thereof
10/17/2012CN102731395A Intermediate compound of antitumor drug neratinib and its preparation method and use
10/17/2012CN102731379A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
10/17/2012CN101412692B 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof
10/17/2012CN101355879B Chemical compounds
10/17/2012CN101316839B Acid addition salt of dihydropyridine derivative
10/16/2012US8288556 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/16/2012US8288550 Crystalline form of a benzimidazole-carboxamide medicinal compound
10/16/2012US8288549 Glycine B antagonist
10/16/2012US8288546 Substituted piperidine compounds and methods of their use
10/16/2012US8288541 Piperazine amide derivatives
10/16/2012US8288540 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288538 Pyridine derivatives and pyrimidine derivatives (3)
10/16/2012US8288531 Preparation process
10/16/2012US8288425 Benzimidazoles
10/16/2012US8288418 Benzimidazole derivatives and their use for modulating the GABAA receptor complex
10/16/2012US8288415 For reducing levels of tumor necrosis factor alpha in mammals; 3-(3-Nitrophthalimido)-3-methylpiperidine-2,6-dione; 1,3-Dioxo-2-(2,6-dioxopiperidin-3-yl)-5-nitroisoindoline
10/16/2012US8288414 Deuterium-enriched lenalidomide
10/16/2012US8288411 Pyrrolidines and piperidines as orexin receptor antagonists
10/16/2012US8288405 N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
10/16/2012US8288403 Heterocyclic gamma secretase modulators
10/16/2012US8288394 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivative
10/16/2012US8288388 3-pyridylcarbonyl-piperazinylsulfonyl derivatives
10/16/2012US8288387 Napthalimide-benzimidazole hybrids as potential antitumor agents and process for the preparation thereof
10/16/2012US8288386 Melanocortin receptor agonists
10/16/2012US8288371 Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
10/16/2012US8288318 2-(poly-substituted aryl)-6-amino-5-halo-4-pyrimidinecarboxylic acids and their use as herbicides
10/16/2012US8288316 N-(1,2,5-oxadiazol-3-yl)benzamides and their use as herbicides
10/16/2012US8287769 Charge transport compositions and electronic devices made with such compositions
10/16/2012CA2697077C 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors
10/16/2012CA2605680C Substituted amide derivatives as protein kinase inhibitors
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2526884C P2x7 receptor antagonists and their use
10/16/2012CA2526866C Substituted 3-sulfur indoles for treating a disease mediated by crth2
10/11/2012WO2012138670A1 Process for the preparation of an hiv integrase inhibitor
10/11/2012WO2012138648A1 Compositions and methods for modulating lpa receptors
10/11/2012WO2012136834A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012WO2012136703A1 Herbicidal compounds
10/11/2012WO2012136684A1 Adamantyl compounds
10/11/2012WO2012136581A1 Fungicide hydroximoyl-tetrazole derivatives
10/11/2012WO2012136504A1 Method for the preparation of process intermediates for the synthesis of argatroban monohydrate
10/11/2012WO2012136492A1 Wnt pathway antagonists
10/11/2012WO2012136099A1 4-(substituted phenylamino)quinazoline derivative and preparation method therefor, pharmaceutical composition and use thereof
10/11/2012WO2012083306A3 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
10/11/2012WO2012083058A3 Anti-viral compounds
10/11/2012WO2012061428A3 Nicotinamides as jak kinase modulators
10/11/2012US20120259123 Aminopyridine compound
10/11/2012US20120259113 Dual-acting pyrazole antihypertensive agents
10/11/2012US20120259094 Affinity ligands and methods for protein purification
10/11/2012US20120258986 Olefin containing nuclear transport modulators and uses thereof
10/11/2012US20120258985 Stabilized polymeric thiol reagents
10/11/2012US20120258978 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258957 Heterocyclic derivatives
10/11/2012US20120258951 Novel antiplatelet agent
10/11/2012US20120258948 N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
10/11/2012US20120258947 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
10/11/2012US20120258513 Selective Neuronal Nitric Oxide Synthase Inhibitors
10/11/2012US20120258170 Pharmaceutical co-crystals of quercetin
10/11/2012US20120258078 Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis c
10/11/2012US20120256174 Compound for an organic photoelectric device, organic photoelectric device including the same, and display device including the organic photoelectric device
10/11/2012CA2832685A1 Pyrimidine derivatives for the treatment of viral infections
10/11/2012CA2832305A1 Wnt pathway antagonists
10/11/2012CA2831987A1 Method for the preparation of process intermediates for the synthesis of argatroban monohydrate
10/11/2012CA2830817A1 Herbicidal compounds
10/11/2012CA2828297A1 Adamantyl compounds
10/10/2012EP2508520A1 Pyrazolone-derivatives as PDE4 inhibitors
10/10/2012EP2508513A1 2-pyridone compounds
10/10/2012EP2507229A1 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/10/2012EP2507227A1 Protein kinase c inhibitors and uses thereof
10/10/2012EP2507226A1 Novel compounds
1 ... 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 ... 1080